Filing Details
- Accession Number:
- 0001209191-21-063273
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-05 19:47:31
- Reporting Period:
- 2021-11-03
- Accepted Time:
- 2021-11-05 19:47:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1020214 | Cerus Corp | CERS | Surgical & Medical Instruments & Apparatus (3841) | 680262011 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1459351 | Dennis Kevin Green | C/O Cerus Corporation 1220 Concord Ave Suite 600 Concord CA 94520 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-11-03 | 95,000 | $3.75 | 248,740 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-11-03 | 81,615 | $7.00 | 167,125 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-03 | 14,126 | $7.00 | 152,999 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (Right to Buy) | Disposition | 2021-11-03 | 95,000 | $0.00 | 95,000 | $3.75 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-02-28 | No | 4 | M | Direct |
Footnotes
- This transaction was executed pursuant to a 10b5-1 plan.
- This transaction was executed pursuant to a 10b5-1 plan. Includes shares required to be sold to cover commission and mandatory tax withholdings on the "sell to cover" transaction described above and does not represent a discretionary sale by the reporting person.
- The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.01 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.
- One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested each month thereafter.
- Not applicable.
Billionaire Hedge Funds
